Global Recombinant Protein Drugs Market Analysis 2015-2019 and Forecast 2020-2025

Publication Month: Feb 2020 | No. of Pages: 87 Published By: 99Strategy
Single User License: US $ 2980
Corporate User License: US $ 5960

Snapshot
The global Recombinant Protein Drugs market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Recombinant Protein Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Recombinant DNA
Recombinant RNA
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono
Ortho Biotech
Roche
Kyowa Hakko Kirin
Pharmingen
Abcam
GenSci
SL PHARM
Dongbao Pharm
Ankebio
NCPC
Heng Rui
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Pharmaceutical Industry
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Content

1 Industry Overview
1.1 Recombinant Protein Drugs Industry
Figure Recombinant Protein Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Recombinant Protein Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Recombinant Protein Drugs
1.2.2 Downstream
Table Application Segment of Recombinant Protein Drugs
Table Global Recombinant Protein Drugs Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Recombinant Protein Drugs Market by Type
3.1 By Type
3.1.1 Recombinant DNA
Table Major Company List of Recombinant DNA
3.1.2 Recombinant RNA
Table Major Company List of Recombinant RNA
3.2 Market Size
Table Global Recombinant Protein Drugs Market 2015-2019, by Type, in USD Million
Figure Global Recombinant Protein Drugs Market Growth 2015-2019, by Type, in USD Million
Table Global Recombinant Protein Drugs Market 2015-2019, by Type, in Volume
Figure Global Recombinant Protein Drugs Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Recombinant Protein Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Recombinant Protein Drugs Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Novo Nordisk (Company Profile, Sales Data etc.)
4.1.1 Novo Nordisk Profile
Table Novo Nordisk Overview List
4.1.2 Novo Nordisk Products & Services
4.1.3 Novo Nordisk Business Operation Conditions
Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Amgen (Company Profile, Sales Data etc.)
4.2.1 Amgen Profile
Table Amgen Overview List
4.2.2 Amgen Products & Services
4.2.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Sanofi (Company Profile, Sales Data etc.)
4.3.1 Sanofi Profile
Table Sanofi Overview List
4.3.2 Sanofi Products & Services
4.3.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Eli Lilly (Company Profile, Sales Data etc.)
4.4.1 Eli Lilly Profile
Table Eli Lilly Overview List
4.4.2 Eli Lilly Products & Services
4.4.3 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Merck Serono (Company Profile, Sales Data etc.)
4.5.1 Merck Serono Profile
Table Merck Serono Overview List
4.5.2 Merck Serono Products & Services
4.5.3 Merck Serono Business Operation Conditions
Table Business Operation of Merck Serono (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Ortho Biotech (Company Profile, Sales Data etc.)
4.6.1 Ortho Biotech Profile
Table Ortho Biotech Overview List
4.6.2 Ortho Biotech Products & Services
4.6.3 Ortho Biotech Business Operation Conditions
Table Business Operation of Ortho Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Roche (Company Profile, Sales Data etc.)
4.7.1 Roche Profile
Table Roche Overview List
4.7.2 Roche Products & Services
4.7.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Kyowa Hakko Kirin (Company Profile, Sales Data etc.)
4.8.1 Kyowa Hakko Kirin Profile
Table Kyowa Hakko Kirin Overview List
4.8.2 Kyowa Hakko Kirin Products & Services
4.8.3 Kyowa Hakko Kirin Business Operation Conditions
Table Business Operation of Kyowa Hakko Kirin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Pharmingen (Company Profile, Sales Data etc.)
4.9.1 Pharmingen Profile
Table Pharmingen Overview List
4.9.2 Pharmingen Products & Services
4.9.3 Pharmingen Business Operation Conditions
Table Business Operation of Pharmingen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Abcam (Company Profile, Sales Data etc.)
4.10.1 Abcam Profile
Table Abcam Overview List
4.10.2 Abcam Products & Services
4.10.3 Abcam Business Operation Conditions
Table Business Operation of Abcam (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 GenSci (Company Profile, Sales Data etc.)
4.11.1 GenSci Profile
Table GenSci Overview List
4.11.2 GenSci Products & Services
4.11.3 GenSci Business Operation Conditions
Table Business Operation of GenSci (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 SL PHARM (Company Profile, Sales Data etc.)
4.12.1 SL PHARM Profile
Table SL PHARM Overview List
4.12.2 SL PHARM Products & Services
4.12.3 SL PHARM Business Operation Conditions
Table Business Operation of SL PHARM (Sales Revenue, Cost, Gross Margin)
4.13 Dongbao Pharm (Company Profile, Sales Data etc.)
4.13.1 Dongbao Pharm Profile
Table Dongbao Pharm Overview List
4.13.2 Dongbao Pharm Products & Services
4.13.3 Dongbao Pharm Business Operation Conditions
Table Business Operation of Dongbao Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Ankebio (Company Profile, Sales Data etc.)
4.14.1 Ankebio Profile
Table Ankebio Overview List
4.14.2 Ankebio Products & Services
4.14.3 Ankebio Business Operation Conditions
Table Business Operation of Ankebio (Sales Revenue, Cost, Gross Margin)
4.15 NCPC (Company Profile, Sales Data etc.)
4.15.1 NCPC Profile
Table NCPC Overview List
4.15.2 NCPC Products & Services
4.15.3 NCPC Business Operation Conditions
Table Business Operation of NCPC (Sales Revenue, Cost, Gross Margin)
4.16 Heng Rui (Company Profile, Sales Data etc.)
4.16.1 Heng Rui Profile
Table Heng Rui Overview List
4.16.2 Heng Rui Products & Services
4.16.3 Heng Rui Business Operation Conditions
Table Business Operation of Heng Rui (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Recombinant Protein Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Recombinant Protein Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Recombinant Protein Drugs Sales Revenue Share in 2019, by Company, in USD Million
Table Global Recombinant Protein Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Recombinant Protein Drugs Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Recombinant Protein Drugs Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Recombinant Protein Drugs Market Concentration, in 2019
Figure Europe Recombinant Protein Drugs Market Market Concentration, in 2019
Figure Asia-Pacific Recombinant Protein Drugs MMarket Concentration, in 2019
Figure South America Recombinant Protein Drugs Market Concentration, in 2019
Figure Middle East & Africa Recombinant Protein Drugs Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Pharmaceutical Industry
Figure Recombinant Protein Drugs Demand in Pharmaceutical Industry, 2015-2019, in USD Million
Figure Recombinant Protein Drugs Demand in Pharmaceutical Industry, 2015-2019, in Volume
6.1.2 Demand in Others
Figure Recombinant Protein Drugs Demand in Others, 2015-2019, in USD Million
Figure Recombinant Protein Drugs Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Recombinant Protein Drugs Demand Forecast 2020-2025, by Application, in USD Million
Figure Recombinant Protein Drugs Market Growth 2020-2025, by Application, in USD Million
Figure Recombinant Protein Drugs Market Share in 2025, by Application, in USD Million
Table Recombinant Protein Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Recombinant Protein Drugs Market Growth 2020-2025, by Application, in Volume
Table Recombinant Protein Drugs Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Recombinant Protein Drugs Production 2015-2019, by Region, in USD Million
Table Recombinant Protein Drugs Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Recombinant Protein Drugs Market 2015-2019, by Region, in USD Million
Table Global Recombinant Protein Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Recombinant Protein Drugs Market 2015-2019, by Region, in Volume
Table Global Recombinant Protein Drugs Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Recombinant Protein Drugs Market Size and Growth 2015-2019, in USD Million
Figure North America Recombinant Protein Drugs Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Recombinant Protein Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Recombinant Protein Drugs Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Recombinant Protein Drugs Market Size and Growth 2015-2019, in USD Million
Figure Europe Recombinant Protein Drugs Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Recombinant Protein Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Recombinant Protein Drugs Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Recombinant Protein Drugs Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Recombinant Protein Drugs Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Recombinant Protein Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Recombinant Protein Drugs Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Recombinant Protein Drugs Market Size and Growth 2015-2019, in USD Million
Figure South America Recombinant Protein Drugs Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Recombinant Protein Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Recombinant Protein Drugs Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Recombinant Protein Drugs Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Recombinant Protein Drugs Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Recombinant Protein Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Recombinant Protein Drugs Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Recombinant Protein Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Recombinant Protein Drugs Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

Tables and Figures

List of Table

List of Table

Table Upstream Segment of Recombinant Protein Drugs
Table Application Segment of Recombinant Protein Drugs
Table Global Recombinant Protein Drugs Market 2015-2025, by Application, in USD Million
Table Major Company List of Recombinant RNA
Table Global Recombinant Protein Drugs Market 2015-2019, by Type, in USD Million
Table Global Recombinant Protein Drugs Market 2015-2019, by Type, in Volume
Table Global Recombinant Protein Drugs Market Forecast 2020-2025, by Type, in USD Million
Table Global Recombinant Protein Drugs Market Forecast 2020-2025, by Type, in Volume
Table Novo Nordisk Overview List
Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Serono Overview List
Table Business Operation of Merck Serono (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ortho Biotech Overview List
Table Business Operation of Ortho Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Overview List
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kyowa Hakko Kirin Overview List
Table Business Operation of Kyowa Hakko Kirin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharmingen Overview List
Table Business Operation of Pharmingen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abcam Overview List
Table Business Operation of Abcam (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GenSci Overview List
Table Business Operation of GenSci (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table SL PHARM Overview List
Table Business Operation of SL PHARM (Sales Revenue, Cost, Gross Margin)
Table Dongbao Pharm Overview List
Table Business Operation of Dongbao Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ankebio Overview List
Table Business Operation of Ankebio (Sales Revenue, Cost, Gross Margin)
Table NCPC Overview List
Table Business Operation of NCPC (Sales Revenue, Cost, Gross Margin)
Table Heng Rui Overview List
Table Business Operation of Heng Rui (Sales Revenue, Cost, Gross Margin)
Table Global Recombinant Protein Drugs Sales Revenue 2015-2019, by Company, in USD Million
Table Global Recombinant Protein Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Recombinant Protein Drugs Sales Volume 2015-2019, by Company, in Volume
Table Global Recombinant Protein Drugs Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Recombinant Protein Drugs Demand Forecast 2020-2025, by Application, in USD Million
Table Recombinant Protein Drugs Demand Forecast 2020-2025, by Application, in Volume
Table Recombinant Protein Drugs Market Growth 2020-2025, by Application, in Volume
Table Recombinant Protein Drugs Market Share in 2025, by Application, in Volume
Table Recombinant Protein Drugs Production 2015-2019, by Region, in USD Million
Table Recombinant Protein Drugs Production 2015-2019, by Region, in Volume
Table Global Recombinant Protein Drugs Market 2015-2019, by Region, in USD Million
Table Global Recombinant Protein Drugs Market Share 2015-2019, by Region, in USD Million
Table Global Recombinant Protein Drugs Market 2015-2019, by Region, in Volume
Table Global Recombinant Protein Drugs Market Share 2015-2019, by Region, in Volume
Table North America Recombinant Protein Drugs Market Size 2015-2019, by Country, in USD Million
Table North America Recombinant Protein Drugs Market Size 2015-2019, by Country, in Volume
Table Europe Recombinant Protein Drugs Market Size 2015-2019, by Country, in USD Million
Table Europe Recombinant Protein Drugs Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Recombinant Protein Drugs Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Recombinant Protein Drugs Market Size 2015-2019, by Country, in Volume
Table South America Recombinant Protein Drugs Market Size 2015-2019, by Country, in USD Million
Table South America Recombinant Protein Drugs Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Recombinant Protein Drugs Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Recombinant Protein Drugs Market Size 2015-2019, by Country, in Volume
Table Recombinant Protein Drugs Market Forecast 2020-2025, by Region, in USD Million
Table Recombinant Protein Drugs Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List

Reason to Buy

  • Current and future of Uncategorized Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Uncategorized Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Uncategorized Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Uncategorized Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets